Exagen XGN
NASDAQ XGN
$8.13 -0.17 (-2.05%)
At close: Sep 30, 2026 · 4:00 PM EDT

Exagen (XGN) Current Deferred Revenue (2024 - 2026)

Updated

Exagen (XGN) posted Current Deferred Revenue of $1.49 million for Q2 2026, up 46.9% from $1.02 million a year earlier and up 119.1% from the prior quarter.

Analysis

Exagen (XGN) Current Deferred Revenue (2024 - 2026) Analysis & Trends

At the end of FY2025, Exagen's Current Deferred Revenue came in at $675,000, down 7.9% from FY2024.

  • In prior years, Exagen's Current Deferred Revenue was $733,000 in FY2024.
  • According to Business Quant data, Current Deferred Revenue for the three prior quarters was $681,000 (Q1 2026), $675,000 (Q4 2025) and $641,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 93.06 Bn 92.50 Bn -
2 Natera 59.36 Bn 55.04 Bn 485.19 Mn
3 Quest Diagnostics 25.72 Bn 24.15 Bn 1.03 Bn
4 Labcorp Holdings 24.93 Bn 22.69 Bn 1.11 Bn
5 Guardant Health 23.83 Bn 19.89 Bn 219.03 Mn
6 Tenet Healthcare 20.58 Bn 11.72 Bn -
7 Tempus AI 14.35 Bn 11.38 Bn 246.50 Mn
8 Encompass Health 11.99 Bn 12.46 Bn -
9 BrightSpring Health Services 11.21 Bn 9.55 Bn 492.75 Mn
10 Exagen 196.69 Mn 82.66 Mn 12.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.49 Mn
Mar 31, 2026 681,000.00
Dec 31, 2025 675,000.00
Sep 30, 2025 641,000.00
Jun 30, 2025 1.02 Mn
Mar 31, 2025 876,000.00
Dec 31, 2024 733,000.00
API Access

Exagen Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=XGN&period=max&api_key=YOUR_API_KEY